Articles related to CLINICAL STUDY

As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.

Explore how the persistence of detectable Epstein-Barr virus DNA can serve as a significant predictive marker for nasopharyngeal cancer, potentially revolutionizing early diagnosis and improving survival rates.

The study findings suggest that acalabrutinib and rituximab, a chemo-free therapy option, may offer a new standard of care for older, untreated MCL patients, with promising early complete responses. Yet, more data is needed to understand long-term safety and risk of relapse.

Discover the potential of xanthine dehydrogenase/oxidase blockers, such as allopurinol, in reducing the risk of neurodegenerative diseases. This large-scale study reveals intriguing associations and sets the stage for future research.

Findings from this trial may reshape how physicians perceive and prescribe testosterone-replacement therapy for middle-aged and older men with hypogonadism, with no substantial rise in major adverse cardiac events reported.

Explore the results of this study, which shed light on the underreported and frequently misunderstood phenomena of “brain zaps” during antidepressant withdrawal and its effects on medicine use and quality of life.